UC	urothelial carcinoma
UTUC	upper urinary tract urothelial carcinoma
BC	bladder cancer
DSS	disease-specific survival
CT	computed tomography
URS	ureterorenoscopy
RNU	radical nephroureterectomy
EAU	European Association of Urology
MIBC	muscle-invasive bladder cancer
OS	overall survival
CPI	checkpoint-Inhibitor
CR	complete remission
NAC	neoadjuvant chemotherapy
MVAC/MVEC	methotrexate, vinblastine, adriamycin/epirubicin and cisplatin
PICO	participants, interventions, comparators, outcomes
PR	partial remission
SD	stable disease
PD	progressive disease
PFS	progression-free survival
GFR	glomerular filtration rate
ECOG	Eastern Cooperative Oncology Group
LVI	lymphovascular invasion
OR	odds ratio
HR	hazard ratio
CI	confidence interval
IPTW	intuition for inverse probability of treatment weighting